VEGFA and melanoma: Following the application of CUR, a decrease in VEGF was observed in the Xenograft model of melanoma in mice and also in HUVECs (human umbilical vein endothelial cells) [128], the Xenograft model of breast cancer [125], and endometriosis [130].